Key facts
- This page summarizes Mark E. Strome's Form 4 filing for Zivo Bioscience, Inc. (ZIVO).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 21 Jan 2025, 08:00.
Mark E. Strome - 17 Jan 2025 Form 4 Insider Report for Zivo Bioscience, Inc. (ZIVO)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- ZIVO
- Reported as of
- 17 Jan 2025
- Net transaction value
- +$629,000
- SEC form
- 4
- Accepted by SEC
- 21 Jan 2025, 08:00:23 UTC
- Prior SEC filing
- 23 Jan 2025
- Next SEC filing
- 02 Oct 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mark E. Strome
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Mark E. Strome filed Form 4 for Zivo Bioscience, Inc. (ZIVO) on 21 Jan 2025.
Change
- Previous filing in this sequence was filed on 23 Jan 2025.
- Current net transaction value: +$629,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ZIVO
transaction
Common Stock
Other
- Transaction value
- $629,000
- Shares
- +34,000
- Change %
- +8.5%
- Price
- $18.50
- Shares after
- 432,683
- Date
- 17 Jan 2025
- Ownership
- By entity
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The reported securities are owned directly by Strome Mezzanine Fund, LP ("SMF"). On January 17, 2025, SMF entered into an Exchange Agreement with the Issuer, pursuant to which in exchange for cancelling the License Co-Development Participation Agreement between the Issuer and SMF dated October 8, 2020, the Issuer agreed to issue to SMF the reported securities.
Footnote F2
Strome Investment Management, LP is the general partner of SMF. Strome Group, Inc. is the general partner of Strome Investment Management, LP. Mark E. Strome is the President and CEO of Strome Group, Inc. Mr. Strome, Strome Investment Management, LP and Strome Group, Inc. (together, the "Reporting Persons") may be deemed to share voting and investment power for and to beneficially own the shares held by SMF under Section 13(d) of the Securities Exchange Act of 1934 (the "Exchange Act").
Footnote F3
Pursuant to Rule 16a-1(a)(4) of the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any equity securities reported herein.